Home

Ausdrücklich Halskette Hand achim aigner leipzig university germany Kritisch klein Kranke Person

Therapeutic Targeting of Stat3 Using Lipopolyplex Nanoparticle-Formulated  siRNA in a Syngeneic Orthotopic Mouse Glioma Model
Therapeutic Targeting of Stat3 Using Lipopolyplex Nanoparticle-Formulated siRNA in a Syngeneic Orthotopic Mouse Glioma Model

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology

Tetraspanin 5 (TSPAN5), a Novel Gatekeeper of the Tumor Suppressor DLC1 and  Myocardin-Related Transcription Factors (MRTFs), Con
Tetraspanin 5 (TSPAN5), a Novel Gatekeeper of the Tumor Suppressor DLC1 and Myocardin-Related Transcription Factors (MRTFs), Con

Functional Role and Therapeutic Potential of the Pim-1 Kinase in Colon  Carcinoma
Functional Role and Therapeutic Potential of the Pim-1 Kinase in Colon Carcinoma

Biocompatibility and Efficacy of Oligomaltose-Grafted Poly(ethylene imine)s  (OM-PEIs) for in Vivo Gene Delivery
Biocompatibility and Efficacy of Oligomaltose-Grafted Poly(ethylene imine)s (OM-PEIs) for in Vivo Gene Delivery

Tyrosine-Modification of Polypropylenimine (PPI) and Polyethylenimine (PEI)  Strongly Improves Efficacy of siRNA-Mediated Gene Kn
Tyrosine-Modification of Polypropylenimine (PPI) and Polyethylenimine (PEI) Strongly Improves Efficacy of siRNA-Mediated Gene Kn

Nanoparticle-mediated delivery of small RNA molecules in tumor therapy
Nanoparticle-mediated delivery of small RNA molecules in tumor therapy

Analysis of SATB1 in Head and Neck Squamous Cell Carcinoma
Analysis of SATB1 in Head and Neck Squamous Cell Carcinoma

Foresee Edebi sanatlar yelken achim aigner leipzig university germany Tren  istasyonu ilgisiz yerine getirmek
Foresee Edebi sanatlar yelken achim aigner leipzig university germany Tren istasyonu ilgisiz yerine getirmek

Silencing of Neuropilins and GIPC1 in pancreatic ductal adenocarcinoma  exerts multiple cellular and molecular antitumor effects | Scientific  Reports
Silencing of Neuropilins and GIPC1 in pancreatic ductal adenocarcinoma exerts multiple cellular and molecular antitumor effects | Scientific Reports

Targeted CRM197-PEG-PEI/siRNA Complexes for Therapeutic RNAi in Glioblastoma
Targeted CRM197-PEG-PEI/siRNA Complexes for Therapeutic RNAi in Glioblastoma

Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate Cancer  Cells In Vitro and In Vivo
Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate Cancer Cells In Vitro and In Vivo

Perspectives, issues and solutions in RNAi therapy: the expected and the  less expected
Perspectives, issues and solutions in RNAi therapy: the expected and the less expected

PDF) The proto-oncogene Pim-1 is a target of miR-33a | Marshall Thomas -  Academia.edu
PDF) The proto-oncogene Pim-1 is a target of miR-33a | Marshall Thomas - Academia.edu

Module III – CAS in Radiopharmaceutical Chemistry/Radiopharmacy | ETH Zurich
Module III – CAS in Radiopharmaceutical Chemistry/Radiopharmacy | ETH Zurich

Nanoparticle-complexed antimiRs for inhibiting tumor growth and metastasis  in prostate carcinoma and melanoma
Nanoparticle-complexed antimiRs for inhibiting tumor growth and metastasis in prostate carcinoma and melanoma

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology

Mitarbeiter des Rudolf-Boehm-Institutes
Mitarbeiter des Rudolf-Boehm-Institutes

Mitarbeiter des Rudolf-Boehm-Institutes
Mitarbeiter des Rudolf-Boehm-Institutes

Multiple effects of the special ATâ•'rich binding protein 1 (SATB1) in  colon carcinoma
Multiple effects of the special ATâ•'rich binding protein 1 (SATB1) in colon carcinoma

Let Life Sciences meet you Let Life Sciences meet you
Let Life Sciences meet you Let Life Sciences meet you

Leipziger Pharmakologen forschen an Molekülen gegen Prostatakrebs
Leipziger Pharmakologen forschen an Molekülen gegen Prostatakrebs